PACIFIC BIOSCIENCES OF CALIFORNIA, INC. |
Director |
Common Stock |
41.6K |
$84.5K |
$2.03 |
Jun 18, 2024 |
Direct |
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. |
Director |
Stock Option (right to buy) |
32.2K |
|
|
Jun 18, 2024 |
Direct |
Adamas Pharmaceuticals Inc |
Director, 10%+ Owner |
Common Stock |
0 |
|
$5.16 |
Nov 24, 2021 |
Direct |
Adamas Pharmaceuticals Inc |
Director, 10%+ Owner |
Common Stock |
0 |
|
$5.16 |
Nov 24, 2021 |
MDV ENF VII (A), L.P. |
Adamas Pharmaceuticals Inc |
Director, 10%+ Owner |
Common Stock |
0 |
|
$5.16 |
Nov 24, 2021 |
MDV ENF VII (B), L.P. |
Adamas Pharmaceuticals Inc |
Director, 10%+ Owner |
Common Stock |
0 |
|
$5.16 |
Nov 24, 2021 |
MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF IX, L.P. |
Adamas Pharmaceuticals Inc |
Director, 10%+ Owner |
Common Stock |
0 |
|
$5.16 |
Nov 24, 2021 |
MDV VII Leaders' Fund, L.P. |
Adamas Pharmaceuticals Inc |
Director, 10%+ Owner |
Common Stock |
0 |
|
$5.16 |
Nov 24, 2021 |
MDV VII, L.P. |
Adamas Pharmaceuticals Inc |
Director, 10%+ Owner |
Common Stock |
0 |
|
$5.16 |
Nov 24, 2021 |
MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP |
Adamas Pharmaceuticals Inc |
Director, 10%+ Owner |
Stock Option (Right to Buy) |
0 |
|
|
Nov 24, 2021 |
Direct |